|Phospho-Tyrosine (P-Tyr-1000) MultiMab™ Rabbit mAb mix 8954||20 µl||
|Met (D1C2) XP® Rabbit mAb 8198||20 µl||
||H||140, 170||Rabbit IgG|
|EGF Receptor (D38B1) XP® Rabbit mAb 4267||20 µl||
||H M Mk||175||Rabbit IgG|
|PDGF Receptor α (D1E1E) XP® Rabbit mAb 3174||20 µl||
||H M||190||Rabbit IgG|
|PDGF Receptor β (28E1) Rabbit mAb 3169||20 µl||
||H M R||190||Rabbit IgG|
|FGF Receptor 1 (D8E4) XP® Rabbit mAb 9740||20 µl||
||H M R Mk||92 , 120, 145||Rabbit IgG|
|FLT3 (8F2) Rabbit mAb 3462||20 µl||
||H M||130 nonglycosylated form;160 glycosylated mature form||Rabbit IgG|
|HER2/ErbB2 (D8F12) XP® Rabbit mAb 4290||20 µl||
||H M||185||Rabbit IgG|
|Anti-rabbit IgG, HRP-linked Antibody 7074||100 µl||
MultiMab™ rabbit monoclonal mix antibodies are prepared by combining individual rabbit monoclonal clones in optimized ratios for the approved applications. Each antibody in the mix is carefully selected based on motif recognition and performance in multiple assays. Each mix is engineered to yield the broadest possible coverage of the modification being studied while ensuring a high degree of specificity for the modification or motif. Total monoclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human Met, the carboxy terminus of human PDGFRα, Ser740 of human FLT3, the amino terminus of human HER2/ErbB2 protein, with a fusion protein containing the cytoplasmic domain of human EGF receptor, with a GST fusion protein containing a carboxy-terminal fragment of human PDGF receptor β, or with a recombinant protein specific to the carboxy terminus of human FGF 1 receptor protein.
Explore pathways + proteins related to this product.
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.